• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYInsights
  • MYBoard
  • Strategy & Consulting
Select Page

Cellular Senescence is a Central Driver of Chronic Kidney Disease-Related Kidney Fibrosis

by MM360 Staff | May 30, 2025 | Myeloma News

Source: Pharmacy Times articles Researchers explore cellular senescence’s role in kidney fibrosis, highlighting potential therapies to combat chronic kidney disease progression. Read More

Helping Patients Navigate GLP-1 Therapy: Practical Strategies for Pharmacists

by MM360 Staff | May 30, 2025 | Myeloma News

Source: Pharmacy Times articles Katherine H. Saunders, MD, DABOM, explores the role of pharmacists in supporting long-term weight management with GLP-1 therapies, including strategies for counseling on lifestyle interventions, managing adverse effects, and ensuring...

NLA 2025: The Complementary Roles of ANGPTL3 and ANGPTL4 in Lipid Regulation and Therapy

by MM360 Staff | May 30, 2025 | Myeloma News

Source: Pharmacy Times articles Sander Kersten, PhD, discusses the distinct roles of ANGPTL3 and ANGPTL4 in lipid metabolism, their interactions with key enzymes, the therapeutic potential of targeting these pathways in lipid-lowering strategies, and important...

Centennial Pharmacy Services in Pennsylvania Highlights a Lifelong Passion for Patient Care

by MM360 Staff | May 30, 2025 | Myeloma News

Source: Pharmacy Times articles The pharmacy is proud to be community focused and patient centered. Read More

Streamlining Pain Management: Shore Medical Center’s Pharmacist-Driven Opioid Conversion Initiative

by MM360 Staff | May 30, 2025 | Myeloma News

Source: Pharmacy Times articles Shore Medical Center enhances patient safety with a pharmacy-driven intravenous to oral opioid conversion protocol, minimizing risks and improving pain management. Read More

Daratumumab and missed sequencing opportunities in transplant-ineligible multiple myeloma: lessons for future trials

by MM360 Staff | May 30, 2025 | Myeloma News

Source: Myeloma : nature.com subject feeds Post Content Read More
« Older Entries
Next Entries »

Recent Content

  • WHO grants nonproprietary name to ovarian cancer cell therapy
  • Putative multiple myeloma susceptibility genes identified by exome sequencing of 347 familial and early-onset cases
  • Carvykti label updated to include survival benefit data in myeloma
  • Addition of daratumumab to standard triplet regimens achieved better survival in newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
  • Inflammatory markers from routine blood tests predict survival in multiple myeloma: a Systematic Review and meta-analysis
  • FDA approves ziftomenib to treat some relapsed leukemia patients
  • (no title)
  • The challenge of non-transplant eligible, newly diagnosed multiple myeloma
  • Camera pill to find pancreatic cancer seeks breakthrough status
  • Camera pill to find pancreatic cancer seeks breakthrough status
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT